Evaluation of Serum Farnesoid X Receptor (FXR) Levels and Their Correlation with Metabolic Parameters Related to Obesity: A Clinical Investigation - Top-Institutions - MDSpire

Evaluation of Serum Farnesoid X Receptor (FXR) Levels and Their Correlation with Metabolic Parameters Related to Obesity: A Clinical Investigation

  • By

  • Zeyneb Irem Yuksel Salduz

  • Rana Turgut

  • Zeynep Seval Coskun

  • Ozge Pasin

  • Murat Kartal

  • Aclan Ozder

  • April 15, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Joslin Diabetes Center
    Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Metabolism
    • Obesity Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Obesity Medicine
    • Metabolic Disorders

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Metabolism
    • Endocrinology
    • Obesity Research

  • #4

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH

    Bethesda, MD

    Key Differentiators

    • Metabolic Disease Research
    • Endocrinology
    • Obesity

Original Source(s)

Evaluation of Serum Farnesoid X Receptor (FXR) Levels and Their Correlation with Metabolic Parameters Related to Obesity: A Clinical Investigation

  • by Zeyneb Irem Yuksel Salduz, Rana Turgut, Zeynep Seval Coskun, Ozge Pasin, Murat Kartal, Aclan Ozder

  • April 15, 2026

Related Content

Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024)

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

Association Between Metabolic Clusters and Microbial Age in High-Risk Populations for Diabetes and Their Potential Impact on Cardiovascular Disease Risk: Cross-Sectional Observational Study